Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Banco Santander Brasil (BSBR) Upgraded to Buy on Superior Earnings Momentum

By Portfolio Grader
Banco Santander Brasil SA (NYSE:BSBR) is one of the 760 companies in the GICS Financials sector, and a member of the 341 company Banks GICS industry group within this sector. BSBR's market value is $37,305.4 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for BSBR puts it 94 among the 341 companies in this industry group, giving it an above-average position; in the top half of the sector with a ranking of 232 among the 760 companies in the sector, and number 1,556 in the nearly 5,000 company Portfolio Grader universe.

The Shazam Deal Makes Sense But it Won’t Move the Apple Inc. Stock Needle

By Luke Lango, InvestorPlace Senior Investment Analyst
Apple's $400 million acquisition of Shazam is a smart move, but its not a reason to buy AAPL stock at all-time highs.

Analytics for Quant Score Make MLP & Strategic Equity Fund (MTP) a Sell

By Portfolio Grader
The current recommendation of Sell for MLP & Strategic Equity Fund (NASDAQ:MTP) is computed using the methods for investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MTP has had from Portfolio Grader for 4 months.

Vertex Pharmaceuticals (VRTX) a Buy on Healthy Sales Growth

By Portfolio Grader
Currently, Vertex Pharmaceuticals Inc (NASDAQ:VRTX) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. This represents no change from the previous week and is the same ranking VRTX has had from Portfolio Grader for 4 months.

Lackluster Quant Score Penalize Regeneron Pharmaceuticals (REGN) Rating

By Portfolio Grader
Portfolio Grader currently ranks Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a Hold. The methods for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking REGN has had from Portfolio Grader for 6 months.

High-Level Quant Score Keep Cellect Biotechnology (APOP) a Buy

By Portfolio Grader
With a $42.0 billion market value, Cellect Biotechnology Ltd (NULL:APOP) ranks in the top decile in its industry group, Biotechnology, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's Portfolio Grader ranking places it 46 among the 350 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 116 among the 782 companies in the sector, and number 670 in the nearly 5,000 company Portfolio Grader universe.

Shire (SHPG) a Sell on Sagging Quant Score

By Portfolio Grader
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months.

Why American Express Purchases Won’t Require Your Signature Any More

By Karl Utermohlen, InvestorPlace Writer
American Express (AXP) is following Discover as it won't require signatures when you buy items with its credit cards starting on April 2018.

Vapid Sales Growth Penalize Biogen (BIIB) Rating

By Portfolio Grader
Currently, Biogen Inc (NASDAQ:BIIB) has a Hold using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Anemic Earnings Growth Drop Time Warner (TWX) to Sell

By Portfolio Grader
Time Warner Inc (NYSE:TWX) is ranked as a Sell using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. TWX has been downgraded from a Hold to a Sell in the last week.

10 Reasons the Tax Plan Is Bad for Stocks

By Will Ashworth, InvestorPlace Contributor
The new tax plan delivers higher corporate profits, but it will end badly for America. Here's what the tax plan means for stocks.

What’s Going on With Famous Dave’s of America, Inc. (DAVE) Stock?

By Karl Utermohlen, InvestorPlace Writer
Famous Dave's of America (DAVE) shares have been skyrocketing Monday afternoon more than 30%. Find out what's been going on with it here.

Strong Quant Score Analytics Drive Upgrade of Lowes (LOW) to Buy

By Portfolio Grader
Currently, Lowes Companies (NYSE:LOW) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. LOW has been upgraded from a Hold to a Buy in the last week.

Charter Communications (CHTR) a Hold on Feeble Earnings Growth

By Portfolio Grader
Charter Communications Inc (NASDAQ:CHTR) is one of 92 companies within the Media GICS industry group, which is in turn part of the 567 company GICS Consumer Discretionary sector. CHTR has a market value of $80.7 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for CHTR puts it 34 among the 92 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 245 among the 567 companies in the sector, and number 2,289 in the nearly 5,000 company Portfolio Grader universe.

Golden Globes 2018: The Nominees Are …

By Karl Utermohlen, InvestorPlace Writer
The Golden Globes 2018 nominees have been unveiled and they include 'The Greatest Showman,' 'The Disaster Artist,' 'I, Tonya' and more.

Netflix’s (NFLX) Healthy Quant Score Make it a Buy

By Portfolio Grader
Portfolio Grader currently ranks Netflix Inc (NASDAQ:NFLX) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

Costco Wholesale (COST) a Buy on Strong Earnings Momentum

By Portfolio Grader
Costco Wholesale Corp (NASDAQ:COST) ranks in the top 10% of its industry group, Food & Staples Retailing, and in the top decile of sector group, Consumer Staples, with a market value of $82.2 billion. From an investment attractiveness vantage point, COST is ranked in the top half of the sector with a ranking of 65 among the 174 companies in the sector; Portfolio Grader's current ranking for COST puts it 7 among the 25 companies in this industry group, giving it an above-average position and number 1,547 in the 5000 company Portfolio Grader company universe.

Take-Two Interactive Software, Inc Stock Is Not Worth the Risk

By Tom Taulli, InvestorPlace Contributor
It’s been a great year for Take-Two Interactive Software, Inc. TTWO's digital strategy has worked beautifully, but TTWO stock is no bargain.

What the Verizon-NFL Deal Means for Subscribers

By Karl Utermohlen, InvestorPlace Writer
Verizon and the NFL have inked a five-year deal worth $2.5 billion that will allow Verizon to stream NFL games on its various channels.
Load More Articles